Recurrent glioblastoma (GBM) or High-Grade Glioma (HGG) remains one of the most challenging neuro-oncological conditions, with limited survival benefit from conventional therapies. Emerging molecularly targeted approaches, particularly Lutetium-177–based peptide receptor radionuclide therapy (PRRT), are showing promise as innovative strategies for select…
RadioiodineTherapy(I-131)forThyroidCancer: How It Works and Who Needs It
Radioiodine Therapy, commonly known as iodine 131 treatment, is an important part ofmodern thyroid cancer treatment and is widely used in advanced nuclear medicine in India.This therapy is especially recommended after thyroid surgery to destroy any remainingthyroid tissue or microscopic cancer…
Lutetium vs Actinium: Choosing the Right Alpha or Beta Strategy
Lutetium-177 and Actinium-225 therapies are transforming precision cancer treatment in India, especially for advanced and metastatic prostate cancer. In recent years, targeted radionuclide therapy has emerged as one of the most advanced treatment options for complex cancers. A common question among…